6 Results for "

LLC0424

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "LLC0424" in MCE Product Catalog:

Cat. No.: HY-161574
CAS No.: 3061315-33-8
Research Areas:  

Cancer

LLC0424 is a potent and selective cereblon-based PROTAC nuclear receptor-binding SET domain-containing 2 (NSD2) degrader. LLC0424 effectively degraded NSD2 with a DC50 of 20 nM in RPMI-8402 cells. LLC0424 selectively induces NSD2 degradation in a cereblon- and proteasome-dependent fashion. (Blue: CRBN ligand (HY-14658), Black: linker (HY-40002); Pink: NSD2 inhibitor (HY-161575)) .
loading...
    loading...
Cat. No.: HY-161575
NSD2 ligand 1 is a NSD2 ligand. NSD2 ligand 1 can be used for synthesis of LLC0424 (HY-161574) (a PROTAC NSD2 degrader) .
loading...
    loading...
Cat. No.: HY-185557
CAS No.: 3063448-59-6
Research Areas:  

Cancer

LLC0424N is a negative control compound designed by methylating the thalidomide moiety of LLC0424 (HY-161574). LLC0424N shows does not induce NSD2 degradation and inhibit growth of acute lymphoblastic leukemia cells with NSD2 mutation. LLC0424N can be used for the research of acute lymphoblastic leukemia .
loading...
    loading...
Cat. No.: HY-161576
CAS No.: 2636798-54-2
Research Areas:  

Cancer

Thalidomide-Pip-N-boc is a conjugate of E3 ligase ligand and linker. Thalidomide-Pip-N-boc is utilized for synthesis of PROTAC Degrader LLC0424 (HY-161574) .
loading...
    loading...
Cat. No.: HY-W1005059
CAS No.: 42472-93-5
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

N-Methylthalidomide is a cereblon ligand derivative that acts as an E3 ubiquitin ligase ligand for the synthesis of PROTAC LLC0424N (HY-185557). LLC0424N serves as a negative control for NSD2 PROTAC degrader LLC0424 (HY-161574), with weak ability to induce NSD2 degradation and low growth inhibitory effect on cancer cells carrying NSD2 mutations .
loading...
    loading...
Cat. No.: HY-185558
CAS No.: 3061315-50-9
Research Areas:  

Others

N-Methylthalidomide-Pip-NHBoc is an E3 ligase ligand-linker conjugate that incorporates the CRBN ligand and a linker. N-Methylthalidomide-Pip-NHBoc can be used to synthesize LLC0424N (HY-185557) .
loading...
    loading...